Bayer has reached a series of agreements to resolve major outstanding Monsanto-related litigation in the U.S., including settlements totalling more than US$10 billion to address legal claims of Roundup herbicide causing non-Hodgkin’s lymphoma, and a US$400 million agreement to settle litigation related to crop damage caused by dicamba herbicide drift. The company says it will… Read More

A recent California court case that found Monsanto guilty and awarded punitive damages of more than US$250 million is one step closer to being put to a re-trial, after superior court judge Suzanne Bolanos gave a tentative ruling to grant the company’s motion for a new trial. The trial at issue centres on California groundskeeper Dewayne… Read More

The ripple effect from Bayer’s acquisition of Monsanto continues in the canola seed business. Canada’s Competition Bureau says it has approved BASF’s purchase of Bayer’s LibertyLink canola system on the condition that BASF sell its own Clearfield production system for canola. “The Commissioner of Competition concluded that BASF’s acquisition of the Bayer assets would likely… Read More

Update, June 29: The CFIA has published its incident report on the discovery of unapproved GM wheat plants in southern Alberta. The agency says it determined it was an isolated case, with no wheat entering the food or feed system, but that it was unable to determine where it came from: “The CFIA in cooperation with… Read More

It’s a done deal. Monsanto shares are no longer trading on the New York Stock Exchange, as Bayer completed its US$63 billion acquisition of Monsanto on Thursday. The actual integration of Monsanto into Bayer — and the coinciding retirement of the Monsanto name — won’t happen immediately, as approval from the U.S. Department of Justice… Read More

With the European Union granting its conditional approval in late March, and U.S. antitrust authorities reportedly set to give their thumbs-up signal, Canada’s competition regulator has yet to issue its decision on Bayer’s proposed acquisition of Monsanto. The US$66 billion deal, which was originally announced in September 2016, has significant implications in the Canadian market,… Read More

The third year of Monsanto BioAg’s BioAdvantage Trials (BAT) wrapped up with a morning event that had co-operators, agronomists, and reps feeling optimistic for the growing season to come. The event was held in Saskatoon, the home of partner brand Novozymes’ headquarters and a hub for Western Canadian Ag. The event would update attendees on… Read More

Bayer has confirmed it will be selling its digital farming business to gain approval of its acquisition of Monsanto instead of licensing the digital assets out to a competing company. In gaining regulatory approval of the deal in Europe, Bayer had agreed to license its digital farming package to BASF. However, in a statement shared… Read More